Why Melatonin Works For Some People And Does Nothing For Others — The Research

Why Melatonin Works for Some People and Does Nothing for Others, The Research

You’ve probably tried melatonin at some point. Maybe it knocked you out beautifully the first time. Or maybe you swallowed a tablet, waited an hour, and stared at the ceiling wondering what everyone else was talking about. Both experiences are completely valid, and both are explained by the science. The real question isn’t whether melatonin works. It’s *why* it works brilliantly for some people, moderately for others, and seemingly not at all for a significant group. What if the answer isn’t about the supplement itself, but about the timing, the dose, the age of the person taking it, and a much more nuanced story about what melatonin actually *does* in the body? Vitacuity has analysed over 1.77 million research papers and selected the most relevant studies on this topic. What follows might genuinely change how you think about your evening routine.

The Science Behind Melatonin: It’s a Clock Signal, Not a Sleeping Pill

Here’s the most important thing to understand about melatonin, and the thing that most people completely miss: it is not a sedative. It doesn’t knock you out the way a sleeping tablet does. It is a *signal*, a chemical message your brain sends to your body that says “darkness is here, it’s time to wind down.” [11]

Your brain produces melatonin naturally via the pineal gland, a tiny structure deep in the brain, in response to darkness. Levels begin rising in the early evening, peak in the middle of the night, and fade by morning. This rise in melatonin doesn’t directly cause sleep, it tells every cell in your body what time it is, lowering the threshold for the transition from wakefulness to sleep. [13]

Melatonin exerts these effects through two specific receptor types: MT1 and MT2. Research published in the *Journal of Pineal Research* in 2024 suggests these receptors do different jobs, MT1 receptors appear to regulate REM sleep (the deep, dreaming phase), while MT2 receptors appear to regulate NREM sleep (the restorative, slow-wave phase). This means melatonin’s influence over sleep is far more complex and targeted than simply “making you drowsy.” [11]

Here’s the critical implication: if melatonin is a clock signal rather than a sedative, it follows that it will work best for people whose problem is a *timing* problem, a circadian rhythm that’s out of sync, and least well for people whose insomnia has entirely different roots, such as anxiety, pain, or sleep apnoea. This single insight explains most of the confusion.

Finding 1: Across 57 Systematic Reviews, the Evidence Consistently Favours Melatonin

Evidence grade: Strong direction of effect, but methodological variability means we should be cautious about magnitude.

A landmark 2025 scoping review published in the *Journal of Clinical Pharmacology* is arguably the most comprehensive synthesis of melatonin research ever conducted. Researchers searched seven databases and included 57 systematic reviews covering 227 meta-analyses. The overlap between primary studies across these reviews was remarkably low (corrected covered area of just 2.5%), meaning they were largely drawing on different bodies of evidence, which makes the consistency of the findings all the more compelling. [2]

Of the 215 meta-analyses comparing melatonin to an inactive placebo, 80.9% favoured melatonin, 7.9% favoured placebo, and 11.2% were unclear. That’s an extraordinary degree of directional consistency across an enormous body of literature. [2]

The side effects reported across these reviews were generally mild, headaches, gastrointestinal discomfort, and dizziness were the most common, with no serious safety signals emerging at typical doses. [2]

The honest caveat? Only 8.8% of the included reviews met all seven predefined criteria for methodological rigour, meaning that while the *direction* of the evidence is clear, the *size* of the effect and the precise conditions under which melatonin works best remain less certain. The science is pointing firmly in one direction, but it hasn’t yet told us everything we need to know about optimising that effect.

Finding 2: Timing Is Everything, Most People Are Taking It Wrong

Evidence grade: Strong (based on 26 RCTs, 1,689 observations)

This is probably the most practically important finding in all the melatonin research, and the one most people have never heard of. A 2024 systematic review and dose-response meta-analysis in *Journal of Sleep Research* analysed 26 randomised controlled trials published between 1987 and 2020, covering 1,689 observations. [6]

The findings on timing were striking. Meta-regression models showed that the longer the gap between taking melatonin and the sleep episode, the greater the reduction in sleep onset latency (the time it takes to fall asleep). Specifically, administering melatonin 3 hours before the intended bedtime produced significantly better results than the standard clinical practice of taking it 30 minutes before bed. [6]

A separate 2025 review reinforced this, recommending administration at around 6 PM, roughly 1 to 2 hours before the desired bedtime, as optimal for regulating circadian rhythms, particularly in elderly patients and those with bedtime resistance. [1]

Why does this matter? Because melatonin isn’t flipping a sleep switch. It’s *advancing your circadian phase*, nudging your body clock earlier so that your natural sleep window opens at the right time. If you take it 30 minutes before bed, you’re not giving it enough runway to do that job. The supplement hasn’t failed. The timing has.

Finding 3: Dose Matters More Than You Think, and Bigger Isn’t Better

Evidence grade: Strong (26 RCTs, dose-response meta-analysis)

The same 2024 meta-analysis that revealed the timing issue also found a clear dose-response relationship. Melatonin’s effectiveness at reducing sleep onset latency and increasing total sleep time increases with dose, peaking at 4 mg per day. [6]

This is significant for two reasons. First, many UK supplements are sold in doses of 1–2 mg, which may be suboptimal for some users. Second, and this is equally important, the most commonly used dose in clinical practice is 2 mg, taken 30 minutes before bed. That’s potentially both too low *and* too late. [6]

However, it’s worth noting that the research also suggests melatonin is not a “more is more” supplement beyond that peak. The dose-response curve plateaus and there is no compelling evidence that doses significantly above 4 mg provide additional benefit. The sweet spot appears to be 4 mg, taken with more lead time than most people currently allow. [6]

Finding 4: Age Is a Major Factor, Melatonin Production Declines as We Get Older

Evidence grade: Strong (consistent across multiple meta-analyses)

One of the clearest patterns in the melatonin research is that it appears to work significantly better in older adults, and there’s a very good biological reason for this. As we age, the pineal gland naturally produces less melatonin. This decline is not trivial; it is thought to be a significant contributor to the increase in sleep difficulties that most people experience from their mid-40s onwards. [14]

A 2023 meta-analysis published in the *Journal of Sleep Research*, covering 22 studies with 4,875 participants, found that prolonged-release (PR) melatonin was significantly effective in reducing objective sleep onset latency in participants with a mean age of 55 and older, with a large effect size on objective sleep efficiency (weighted difference of 2.95%). This compares to a smaller effect size in younger adults. [7]

A separate 2022 systematic review noted that in adults under 55, melatonin did not appear significantly effective for chronic insomnia in non-comorbid cases, but was effective in children and adolescents, and in adults with comorbid conditions. [8]

The implication is important for Vitacuity’s core audience: if you’re in your 40s, 50s or 60s and struggling with sleep, there is a genuine biological argument for melatonin that doesn’t exist to the same degree for a 25-year-old. Your natural production is declining, and supplementation is essentially restoring what your body is no longer making in sufficient quantities. [14]

Finding 5: Circadian Timing, Your Internal Clock May Be Out of Sync in Ways You Can’t Feel

Evidence grade: Promising (128 participants, single study)

A 2025 study published in the *Journal of Pineal Research* recruited 128 people diagnosed with insomnia disorder and measured their actual circadian timing using salivary melatonin collection, specifically, the “Dim Light Melatonin Onset” (DLMO), which is the time of evening when melatonin levels naturally begin to rise. [4]

The researchers found that DLMO timing was significantly associated with sleep onset time and other measures of sleep continuity. In other words, when your internal melatonin signal fires *later* than it should, a phenomenon known as circadian misalignment, you will struggle to fall asleep at a conventional hour regardless of how tired you feel. [4]

This is the hidden reason melatonin doesn’t work for some people when taken at a fixed clock time: if your DLMO is naturally delayed (say, it fires at midnight instead of 9 PM), then taking melatonin at 10 PM may not be early enough to shift your rhythm. You need to work backwards from your personal circadian timing, not from the clock on the wall. [4]

This also explains why melatonin is genuinely effective for jet lag and shift work, situations where the mismatch between your body clock and the external world is clear and well-defined. Supplemental melatonin has a known, mechanistic job to do in those contexts. [1]

Finding 6: Prolonged-Release Formulations May Outperform Standard Tablets

Evidence grade: Promising to Strong (22 studies, 4,875 participants)

Not all melatonin supplements are created equal. The 2023 meta-analysis in the *Journal of Sleep Research* found that prolonged-release (PR) melatonin was the formulation with the strongest evidence base for insomnia, particularly in older adults. [7]

Standard immediate-release melatonin produces a rapid spike in blood levels, mimicking, roughly, the body’s natural rise. Prolonged-release formulations release melatonin gradually over several hours, which more closely mirrors the sustained overnight elevation of natural melatonin. For people who fall asleep relatively easily but wake in the night, a common complaint in the over-50 age group, prolonged-release formulations may be significantly more effective. [7] [14]

This distinction rarely appears on supplement labels or in consumer advice, but it may be one of the most important variables determining whether melatonin works for you.

Finding 7: Melatonin and the MT1/MT2 Receptor Story, Why “More Melatonin” Isn’t the Whole Answer

Evidence grade: Early stage (predominantly animal and receptor studies)

The 2024 review in *Journal of Pineal Research* made a genuinely important point that reframes the entire melatonin conversation. [11]

Sleep regulation by melatonin doesn’t depend only on how much melatonin is circulating in the blood. It also depends critically on: – The expression of MT1 and MT2 receptors in various brain regions – The molecular sensitivity of those receptors – The specific brain nuclei where those receptors are located

MT1 receptors are primarily associated with REM sleep regulation. MT2 receptors are primarily associated with NREM sleep regulation. Different individuals may have variations in receptor expression or sensitivity that explain why the same dose of melatonin produces profound sleep effects in one person and none in another. [11]

Research in nocturnal mice published in 2024 further demonstrated that endogenous melatonin reduces the threshold for transitioning from wake to sleep, a subtle but important finding, suggesting that melatonin’s job is to make sleep *easier to fall into*, rather than to force it. [13] This is consistent with the clinical observation that melatonin tends to work best when conditions for sleep are already reasonably good, and that it has weaker effects in people with severe, anxiety-driven insomnia.

Importantly, the research suggests that future therapies may involve selective MT1 or MT2 receptor ligands rather than crude melatonin supplementation, a sign that we’re still in relatively early days of understanding how to fully harness this system. [11]

What We Don’t Know Yet

Let’s be honest about the gaps, because there are real ones, and they matter.

The effect size question. Across all the meta-analyses, the effects of melatonin on sleep onset latency tend to be statistically significant but modest. The 2023 meta-analysis found PR melatonin reduced subjective sleep onset latency by just over 6 minutes and increased objective sleep efficiency by under 2% on average across all adults. [7] Whether that is clinically meaningful depends enormously on the individual. For some people, 6 minutes off sleep onset latency is transformative; for others, it’s noise.

Why some adults don’t respond at all. The 2022 systematic review found that in non-comorbid adult insomnia, melatonin was not significantly effective as a group. [8] But “not significant as a group” doesn’t mean “doesn’t work for anyone in that group.” We don’t yet have good tools to predict *in advance* who will respond and who won’t. Individual variability in DLMO timing, receptor expression, and the underlying cause of insomnia all likely play a role, but we can’t yet test for these reliably in clinical practice.

Long-term effects of chronic use. The research on chronic melatonin administration is still evolving. A 2023 review noted that while short-term use is well-tolerated, there remains limited data on the physiological consequences of long-term, daily supplementation, particularly in terms of any potential effect on the body’s own melatonin production. [15] This is worth watching.

Formulation consistency. Because melatonin is sold as a supplement (not a regulated pharmaceutical in many countries), product quality varies enormously. Studies are done on pharmaceutical-grade preparations; what you buy over the counter may differ significantly in actual melatonin content. [14]

The receptor story is still being written. Almost all of the MT1/MT2 receptor research is in animals or in vitro (cell studies). The human implications are promising and scientifically logical, but we don’t yet have clinical trials that specifically target these receptor subtypes in humans. [11]

The Final Takeaway

Here’s what a sensible, well-informed person should actually *do* with all of this.

Melatonin is not a lottery. Whether it works for you is largely predictable, if you understand what it actually does.

First: get the timing right. This is the single change most likely to make the difference. Most people take melatonin 30 minutes before bed. The research says that 2–3 hours before your intended sleep time is significantly more effective. [6] [1] If you go to bed at 11 PM, take melatonin at 8 or 9 PM. That alone may change your experience completely.

Second: consider the dose. The dose-response evidence peaks at 4 mg. If you’ve been using 1 mg and noticed little effect, there is a reasonable, evidence-based case for moving to a higher dose. [6] Melatonin is water-soluble and excess is excreted, it does not accumulate in fat tissue the way some fat-soluble compounds do, and it has a very well-established short-term safety profile at doses up to 10 mg. For most healthy adults, supplementing at 2–4 mg is a safe and practical default.

Third: if you’re over 45, your natural production is almost certainly declining. The biological case for supplementation gets stronger with age, not weaker. This is one of the more convincing arguments for melatonin as a long-term habit rather than an occasional intervention. [14] [7]

Fourth: consider prolonged-release if your problem is staying asleep, not falling asleep. Standard immediate-release tablets are designed for sleep onset. If you wake at 3 AM, a prolonged-release formulation may address what standard melatonin cannot. [7]

Fifth: manage your light environment. Melatonin is suppressed by blue light, the kind emitted by phones, tablets and bright overhead lighting. Taking melatonin at 9 PM and then scrolling through your phone until midnight is working directly against yourself. The supplement and the behaviour need to align.

Finally: be realistic about what melatonin can and cannot do. If your insomnia is primarily driven by anxiety, chronic stress, sleep apnoea, or severe depression, melatonin is unlikely to be sufficient on its own. It is a circadian signal, not a psychiatric drug. But for the very common experience of a body clock that’s drifted late, age-related melatonin decline, or difficulty winding down in the early evening, the evidence supports it clearly, and the risk profile is very favourable.

The science, across more than a decade of systematic reviews and meta-analyses, is consistent: melatonin works. Whether it works *for you* depends on whether you’re giving it the right conditions to do its job.

References

[1] Melatonin dose and timing: Do we have it right? (2025). DOI: 10.1017/S109285292510062X | https://pubmed.ncbi.nlm.nih.gov/41126740/

[2] Exogenous Melatonin and Sleep Quality: A Scoping Review of Systematic Reviews (2025). DOI: 10.1002/jcph.70115 | https://pubmed.ncbi.nlm.nih.gov/41014554/

[3] Melatonin Supplementation Enhances Next-Day High-Intensity Exercise Performance and Recovery in Trained Males: A Placebo-Controlled Crossover Study (2025). https://pubmed.ncbi.nlm.nih.gov/40559702/

[4] Circadian Rhythm Timing and Associations With Sleep Symptoms in People With Insomnia (2025). DOI: 10.1111/jpi.70069 | https://pubmed.ncbi.nlm.nih.gov/40761139/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12322714/

[5] Status of research on the application of melatonin in insomnia based on bibliometric visualization analysis and development trends (2025). DOI: 10.3389/fpsyt.2025.1640198 | https://pubmed.ncbi.nlm.nih.gov/41089313/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12515902/

[6] Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis (2024). https://pubmed.ncbi.nlm.nih.gov/38888087/

[7] Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and meta-analysis (2023). DOI: 10.1111/jsr.13939 | https://pubmed.ncbi.nlm.nih.gov/37434463/

[8] Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses (2022). DOI: 10.1016/j.smrv.2022.101692 | https://pubmed.ncbi.nlm.nih.gov/36179487/

[9] Unlocking the Heart’s Guardian: Exploring Melatonin’s Impact on the Cardiovascular System (2024). DOI: 10.1097/CRD.0000000000000822 | https://pubmed.ncbi.nlm.nih.gov/39625306/

[11] Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views (2024). DOI: 10.1111/jpi.13011 | https://pubmed.ncbi.nlm.nih.gov/39400423/

[13] Melatonin’s role in the timing of sleep onset is conserved in nocturnal mice (2024). https://pubmed.ncbi.nlm.nih.gov/39493889/

[14] Melatonin in sleep disorders (2022). https://pubmed.ncbi.nlm.nih.gov/36064286/

[15] Chronic Administration of Melatonin: Physiological and Clinical Considerations (2023). https://pubmed.ncbi.nlm.nih.gov/36976674/

This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.